Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes

Abstract

The prevalence of type 2 diabetes (T2DM) is increasing rapidly and the age of presentation is falling. These changes are likely to be linked to the current obesity epidemic. Our objective was to compare the characteristics of younger patients with T2DM (diagnosed at age < 40 years) with those of older patients (diagnosed at age 50–70 years).

We identified 149 younger patients with T2DM, from our diabetes clinic database, and compared them with 217 older T2DM patients randomly identified from the same database.

Younger patients with T2DM were more obese, more hypertriglyceridaemic, with lower high-density lipoprotein (HDL) cholesterol, higher total cholesterol/HDL ratio and worse initial and ongoing glycaemic control than older patients from the same clinic. Additional cardiovascular risk factors are associated with T2DM in the young. Treatment should be aimed at early modification of lifestyle and other forms of therapy to avoid long-term complications.

Keywords

early onset type 2 diabetes obesity dyslipidaemia cardiovascular risk

References

1. Hillier TA , Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 2001;24:1522–7.

2. Mokdad AH , Ford ES , Bowman BA et al. Diabetes trends in the US: 1990–1998. Diabetes Care 2000;23:1278–83.

3. Sicree R , Shaw JE , Zimmet PZ. Global and social implications of the diabetes epidemic. Nature 2001;414:782–7.

4. Alberti G , Zimmet P , Shaw J , Bloomgarden Z , Kaufman F , Silink M. Type 2 diabetes in the young: The evolving epidemic: International Diabetes Federation consensus workshop. Diabetes Care 2004;27:1798–811.

5. Mokdad AH , Serdula MK , Dietz WH , Bowman BA , Marks JS , Koplan JP. The spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999;181:1519–22.

6. McQuaid S , O'Gorman D , Yousif O et al. Early onset insulin resistant diabetes in obese Caucasians has features of typical type 2 diabetes, but three decades earlier. Diabetes Care 2005;28:1216–18.

7. Hillier TA , Pedula KL. Complications in young adults with early-onset type 2 diabetes. Diabetes Care 2003;26:2999–3005.

8. Health Promotion Unit (Ireland) : National Health and Lifestyle Surveys. Dublin, Department of Health and Children, 2003.

9. Lissau I , Overpeck MD , Ruan WJ , Due P , Holstein BE , Hediger ML: the HBSC obesity working group . Body mass index and overweight in adolescents in 13 European countries, Israel, and United States. Arch Paediatr Adolesc Med 2004;158:27–33.

10.

10. Moss SEM , Klein R , Klein BEK , Meuer SM. The association of glycaemia and cause-specific mortality in diabetic population. Arch Intern Med 1994;154:2473–9.

11.

11. Uusitupa MIJ , Niskanen LK , Siitronen O , Voutilainen E , Pyorala K. Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 diabetic and non diabetic subjects. Diabetologia 1993;36:1175–84.

12.

12. UK Prospective Study Group : UK Prospective Diabetes Study 16. Overview of six years therapy of type 2 diabetes: a progressive disease. Diabetes 1995;44:1249–58.

13.

13. Niskanen LK , Turpeinen A , Ilkka P , Uusitupa MIJ. Hyperglycaemia and compositional lipoprotein abnormalities as predictor of cardiovascular mortality in type 2 diabetes. Diabetes Care 1998;21:1861–9.

14.

14. Garg A , Grundy SM. Management of dyslipidaemia in NIDDM. Diabetes Care 1990;13:153–69.

15.

15. Jiang R , Schulze MB , Li T et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 2004;27:1991–7.

16.

16. Kinosian B , Glick H , Preiss L , Puder KL. Cholesterol and coronary heart disease: predicting risks in men by change in levels and ratios. J Investig Med 1995;43:443–50.